Efficacy of erythroid‐stimulating agent and luspatercept in VEXAS syndrome: A multicenter retrospective study by the FRENVEX group

Saved in:
Bibliographic Details
Main Authors: Maël Heiblig, Vincent Jachiet, Jérôme Hadjadj, Lin Pierre Zhao, Thibault Comont, Hervé Lobbes, Valentin Lacombe, Anne Blandine Boutin, Joris Galland, Benjamin Terrier, Sophie Georgin‐Lavialle, Pierre Fenaux, Arsène Mekinian, the FRENVEX Group
Format: Article
Language:English
Published: Wiley 2025-06-01
Series:HemaSphere
Online Access:https://doi.org/10.1002/hem3.70156
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849426625491369984
author Maël Heiblig
Vincent Jachiet
Jérôme Hadjadj
Lin Pierre Zhao
Thibault Comont
Hervé Lobbes
Valentin Lacombe
Anne Blandine Boutin
Joris Galland
Benjamin Terrier
Sophie Georgin‐Lavialle
Pierre Fenaux
Arsène Mekinian
the FRENVEX Group
author_facet Maël Heiblig
Vincent Jachiet
Jérôme Hadjadj
Lin Pierre Zhao
Thibault Comont
Hervé Lobbes
Valentin Lacombe
Anne Blandine Boutin
Joris Galland
Benjamin Terrier
Sophie Georgin‐Lavialle
Pierre Fenaux
Arsène Mekinian
the FRENVEX Group
author_sort Maël Heiblig
collection DOAJ
format Article
id doaj-art-ffbdf5f0de4943a69613a8e36bad06bc
institution Kabale University
issn 2572-9241
language English
publishDate 2025-06-01
publisher Wiley
record_format Article
series HemaSphere
spelling doaj-art-ffbdf5f0de4943a69613a8e36bad06bc2025-08-20T03:29:18ZengWileyHemaSphere2572-92412025-06-0196n/an/a10.1002/hem3.70156Efficacy of erythroid‐stimulating agent and luspatercept in VEXAS syndrome: A multicenter retrospective study by the FRENVEX groupMaël Heiblig0Vincent Jachiet1Jérôme Hadjadj2Lin Pierre Zhao3Thibault Comont4Hervé Lobbes5Valentin Lacombe6Anne Blandine Boutin7Joris Galland8Benjamin Terrier9Sophie Georgin‐Lavialle10Pierre Fenaux11Arsène Mekinian12the FRENVEX GroupHospices Civils de Lyon, Hôpital Lyon Sud, Service d'hématologie Clinique Lyon FranceSorbonne University, Service de Médecine Interne Hôpital Saint‐Antoine, AP‐HP Paris FranceSorbonne University, Service de Médecine Interne Hôpital Saint‐Antoine, AP‐HP Paris FranceHématologie Seniors Assistance Publique des Hôpitaux de Paris (APHP) Nord, Hôpital Saint‐Louis Université Paris Cité Paris FranceService de Médecine Interne et Immunologie Clinique IUCT Oncopole, CHU de Toulouse Toulouse FranceService de Médecine Interne, CHU de Clermont‐Ferrand Hôpital Estaing Clermont‐Ferrand FranceDepartment of Internal Medicine Centre Hospitalier du Haut‐Anjou Chateau‐Gontier FranceDepartment of Hematology Centre Hospitalier Alpes Lémant Contamine‐sur‐Arve FranceService de Médecine Interne, Centre Hospitalier Bourg‐en‐Bresse Hôpital Fleyriat Bourg‐en‐Bresse FranceDepartment of Internal Medicine, AP‐HP, Cochin Hospital University of Paris Paris FranceSorbonne University, Department of Internale Medicine Tenon Hospital, AP‐HP and ERN RITA Paris FranceHématologie Seniors Assistance Publique des Hôpitaux de Paris (APHP) Nord, Hôpital Saint‐Louis Université Paris Cité Paris FranceSorbonne University, Service de Médecine Interne Hôpital Saint‐Antoine, AP‐HP Paris Francehttps://doi.org/10.1002/hem3.70156
spellingShingle Maël Heiblig
Vincent Jachiet
Jérôme Hadjadj
Lin Pierre Zhao
Thibault Comont
Hervé Lobbes
Valentin Lacombe
Anne Blandine Boutin
Joris Galland
Benjamin Terrier
Sophie Georgin‐Lavialle
Pierre Fenaux
Arsène Mekinian
the FRENVEX Group
Efficacy of erythroid‐stimulating agent and luspatercept in VEXAS syndrome: A multicenter retrospective study by the FRENVEX group
HemaSphere
title Efficacy of erythroid‐stimulating agent and luspatercept in VEXAS syndrome: A multicenter retrospective study by the FRENVEX group
title_full Efficacy of erythroid‐stimulating agent and luspatercept in VEXAS syndrome: A multicenter retrospective study by the FRENVEX group
title_fullStr Efficacy of erythroid‐stimulating agent and luspatercept in VEXAS syndrome: A multicenter retrospective study by the FRENVEX group
title_full_unstemmed Efficacy of erythroid‐stimulating agent and luspatercept in VEXAS syndrome: A multicenter retrospective study by the FRENVEX group
title_short Efficacy of erythroid‐stimulating agent and luspatercept in VEXAS syndrome: A multicenter retrospective study by the FRENVEX group
title_sort efficacy of erythroid stimulating agent and luspatercept in vexas syndrome a multicenter retrospective study by the frenvex group
url https://doi.org/10.1002/hem3.70156
work_keys_str_mv AT maelheiblig efficacyoferythroidstimulatingagentandluspaterceptinvexassyndromeamulticenterretrospectivestudybythefrenvexgroup
AT vincentjachiet efficacyoferythroidstimulatingagentandluspaterceptinvexassyndromeamulticenterretrospectivestudybythefrenvexgroup
AT jeromehadjadj efficacyoferythroidstimulatingagentandluspaterceptinvexassyndromeamulticenterretrospectivestudybythefrenvexgroup
AT linpierrezhao efficacyoferythroidstimulatingagentandluspaterceptinvexassyndromeamulticenterretrospectivestudybythefrenvexgroup
AT thibaultcomont efficacyoferythroidstimulatingagentandluspaterceptinvexassyndromeamulticenterretrospectivestudybythefrenvexgroup
AT hervelobbes efficacyoferythroidstimulatingagentandluspaterceptinvexassyndromeamulticenterretrospectivestudybythefrenvexgroup
AT valentinlacombe efficacyoferythroidstimulatingagentandluspaterceptinvexassyndromeamulticenterretrospectivestudybythefrenvexgroup
AT anneblandineboutin efficacyoferythroidstimulatingagentandluspaterceptinvexassyndromeamulticenterretrospectivestudybythefrenvexgroup
AT jorisgalland efficacyoferythroidstimulatingagentandluspaterceptinvexassyndromeamulticenterretrospectivestudybythefrenvexgroup
AT benjaminterrier efficacyoferythroidstimulatingagentandluspaterceptinvexassyndromeamulticenterretrospectivestudybythefrenvexgroup
AT sophiegeorginlavialle efficacyoferythroidstimulatingagentandluspaterceptinvexassyndromeamulticenterretrospectivestudybythefrenvexgroup
AT pierrefenaux efficacyoferythroidstimulatingagentandluspaterceptinvexassyndromeamulticenterretrospectivestudybythefrenvexgroup
AT arsenemekinian efficacyoferythroidstimulatingagentandluspaterceptinvexassyndromeamulticenterretrospectivestudybythefrenvexgroup
AT thefrenvexgroup efficacyoferythroidstimulatingagentandluspaterceptinvexassyndromeamulticenterretrospectivestudybythefrenvexgroup